FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

36602311000001108: SyreniRing 0.12mg/0.015mg per day vaginal delivery system (Crescent Pharma Ltd) 3 system (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 20-Feb 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
112471201000001111 SyreniRing 0.12mg/0.015mg per day vaginal delivery system (Crescent Pharma Ltd) 3 system (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
112471301000001119 SyreniRing 0.12mg/0.015mg per day vaginal delivery system (Crescent Pharma Ltd) 3 system en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
SyreniRing 0.12mg/0.015mg per day vaginal delivery system (Crescent Pharma Ltd) 3 system Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
SyreniRing 0.12mg/0.015mg per day vaginal delivery system (Crescent Pharma Ltd) 3 system Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
SyreniRing 0.12mg/0.015mg per day vaginal delivery system (Crescent Pharma Ltd) 3 system Is a Etonogestrel 11.7mg / Ethinylestradiol 2.7mg vaginal delivery system 3 system true Inferred relationship Existential restriction modifier
SyreniRing 0.12mg/0.015mg per day vaginal delivery system (Crescent Pharma Ltd) 3 system Has AMP SyreniRing 0.12mg/0.015mg per day vaginal delivery system (Crescent Pharma Ltd) true Inferred relationship Existential restriction modifier
SyreniRing 0.12mg/0.015mg per day vaginal delivery system (Crescent Pharma Ltd) 3 system Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
SyreniRing 0.12mg/0.015mg per day vaginal delivery system (Crescent Pharma Ltd) 3 system VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
SyreniRing 0.12mg/0.015mg per day vaginal delivery system (Crescent Pharma Ltd) 3 system VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
SyreniRing 0.12mg/0.015mg per day vaginal delivery system (Crescent Pharma Ltd) 3 system Has specific active ingredient Ethinylestradiol true Inferred relationship Existential restriction modifier
SyreniRing 0.12mg/0.015mg per day vaginal delivery system (Crescent Pharma Ltd) 3 system Has specific active ingredient Etonogestrel true Inferred relationship Existential restriction modifier
SyreniRing 0.12mg/0.015mg per day vaginal delivery system (Crescent Pharma Ltd) 3 system Has dispensed dose form Vaginal delivery system true Inferred relationship Existential restriction modifier
SyreniRing 0.12mg/0.015mg per day vaginal delivery system (Crescent Pharma Ltd) 3 system Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
SyreniRing 0.12mg/0.015mg per day vaginal delivery system (Crescent Pharma Ltd) 3 system Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
SyreniRing 0.12mg/0.015mg per day vaginal delivery system (Crescent Pharma Ltd) 3 system Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start